According to Figure 2A, the expression level of PSAT1 in the tumor tissues of BLCA, Cervical squamous cell carcinoma and Endocervical adenocarcinoma (CESC), Colon adenocarcinoma (COAD), Esophageal carcinoma (ESCA), Head and neck squamous cell carcinoma (HNSC), LUAD, LUSC, Prostate adenocarcinoma (PRAD), Rectum adenocarcinoma (READ), Stomach adenocarcinoma (STAD), and Uterine Corpus Endometrial Carcinoma (UCEC) is higher than the corresponding normal control tissues. This evidence concerns the gene PSAT1 and bladder transitional cell carcinoma.